Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572110
Project Independence: Randomized Controlled TrialUniversity of MiamiNot Yet RecruitingNot Applicable
NCT07572110Not Yet Recruiting
Not Applicable
Project Independence: Randomized Controlled TrialUniversity of Miami
NCT07573631
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular DystrophyBioMarin PharmaceuticalEnrolling By InvitationPhase 2
NCT07573631Enrolling By Invitation
Phase 2
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of B...BioMarin Pharmaceutical
NCT07574073
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaQi dengNot Yet RecruitingPhase 1
NCT07574073Not Yet Recruiting
Phase 1
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refrac...Qi deng
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07574021
The Experience of Short Video Addiction Among College StudentsSun Yat-sen UniversityNot Yet Recruiting
NCT07574021Not Yet Recruiting
—
The Experience of Short Video Addiction Among College StudentsSun Yat-sen University
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07573254
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational Tennis Players With Mechanical Low Back PainIstinye UniversityCompletedNot Applicable
NCT07573254Completed
Not Applicable
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational...Istinye University
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07572552
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With SepsisTanta UniversityNot Yet RecruitingPhase 2
NCT07572552Not Yet Recruiting
Phase 2
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymar...Tanta University
NCT07572409
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory StudymanxiaxiaRecruitingNot Applicable
NCT07572409Recruiting
Not Applicable
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Singl...manxiaxia
NCT07574359
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes in the Russian PopulationPirogov Russian National Research Medical UniversityRecruiting
NCT07574359Recruiting
—
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes...Pirogov Russian National...
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07574307
Kinesiotaping in Isolated Meniscus InjuriesBandırma Onyedi Eylül UniversityRecruitingNot Applicable
NCT07574307Recruiting
Not Applicable
Kinesiotaping in Isolated Meniscus InjuriesBandırma Onyedi Eylül Uni...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572318
Pilot Study on the Feasibility of High-energy Collimation With Optimized Geometry on a VERITON™ CZT CameraCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07572318Not Yet Recruiting
Not Applicable
Pilot Study on the Feasibility of High-energy Collimation With Optimized Geometr...Central Hospital, Nancy,...
NCT07574268
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled TrialMenoufia UniversityCompletedPhase 4
NCT07574268Completed
Phase 4
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men Wi...Menoufia University
NCT07572591
Ultrasound for Peripheral Nerve ModulationStanford UniversityNot Yet RecruitingNot Applicable
NCT07572591Not Yet Recruiting
Not Applicable
Ultrasound for Peripheral Nerve ModulationStanford University
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting4 (20%)
Completed3 (15%)
Enrolling by invitation1 (5%)
Unknown1 (5%)
not_applicable9 (45%)
Phase 24 (20%)
Not Specified4 (20%)
Phase 12 (10%)
Phase 41 (5%)